- Home
- MNPR vs OPOF Comparison
MNPR vs OPOF Comparison
Compare MNPR & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- OPOF
- Stock Information
- Founded
- MNPR 2014
- OPOF 1922
- Country
- MNPR United States
- OPOF United States
- Employees
- MNPR 12
- OPOF N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- OPOF Major Banks
- Sector
- MNPR Health Care
- OPOF Finance
- Exchange
- MNPR Nasdaq
- OPOF Nasdaq
- Market Cap
- MNPR 292.9M
- OPOF 123.9M
- IPO Year
- MNPR 2019
- OPOF N/A
- Fundamental
- Price
- MNPR $48.50
- OPOF $24.60
- Analyst Decision
- MNPR Strong Buy
- OPOF
- Analyst Count
- MNPR 4
- OPOF 0
- Target Price
- MNPR $43.00
- OPOF N/A
- AVG Volume (30 Days)
- MNPR 67.7K
- OPOF 3.5K
- Earning Date
- MNPR 03-27-2025
- OPOF 01-30-2025
- Dividend Yield
- MNPR N/A
- OPOF 2.28%
- EPS Growth
- MNPR N/A
- OPOF 22.03
- EPS
- MNPR N/A
- OPOF 1.88
- Revenue
- MNPR N/A
- OPOF $60,914,000.00
- Revenue This Year
- MNPR N/A
- OPOF N/A
- Revenue Next Year
- MNPR N/A
- OPOF N/A
- P/E Ratio
- MNPR N/A
- OPOF $13.12
- Revenue Growth
- MNPR N/A
- OPOF 2.43
- 52 Week Low
- MNPR $1.55
- OPOF $13.49
- 52 Week High
- MNPR $49.98
- OPOF $28.00
- Technical
- Relative Strength Index (RSI)
- MNPR 66.31
- OPOF 51.16
- Support Level
- MNPR $34.41
- OPOF $24.01
- Resistance Level
- MNPR $44.86
- OPOF $24.85
- Average True Range (ATR)
- MNPR 5.69
- OPOF 0.35
- MACD
- MNPR 1.13
- OPOF -0.15
- Stochastic Oscillator
- MNPR 91.91
- OPOF 44.24
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.